| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN ST, SAN FRANCISCO | /s/ Shane Kovacs, Attorney-in-Fact | 23 Dec 2025 | 0001831216 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OLMA | Common Stock | Sale | $34,398 | -1,225 | -0.2% | $28.08 | 601,656 | 19 Dec 2025 | Direct | F1, F2, F3 |
| transaction | OLMA | Common Stock | Sale | $1,329,362 | -43,729 | -7.3% | $30.40 | 557,927 | 19 Dec 2025 | Direct | F4 |
| transaction | OLMA | Common Stock | Sale | $189,784 | -6,046 | -1.1% | $31.39 | 551,881 | 19 Dec 2025 | Direct | F5 |
| transaction | OLMA | Common Stock | Gift | $0 | -9,000 | -1.6% | $0.000000 | 542,881 | 19 Dec 2025 | Direct | |
| holding | OLMA | Common Stock | 12,831 | 19 Dec 2025 | See Footnote | F6 | |||||
| holding | OLMA | Common Stock | 154,846 | 19 Dec 2025 | See Footnote | F7 |
| Id | Content |
|---|---|
| F1 | The weighted average sale price for the transaction reported was $28.08, and the range of prices was between $28.075 and $28.130. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| F2 | On December 11, 2024, the Reporting Person filed a Form 4 that contained a scrivener's error that resulted in the number of shares beneficially owned directly by the Reporting Person to be understated by 60 shares. That error has been corrected in this Form 4. |
| F3 | Includes 4,488 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025. |
| F4 | The weighted average sale price for the transaction reported was $30.40, and the range of prices was between $30.00 and $30.995. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided |
| F5 | The weighted average sale price for the transaction reported was $31.39, and the range of prices was between $31.00 and $31.595. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| F6 | The shares are held by The Myles Family Revocable Inter Vivos Trust, of which the Reporting Person is trustee. |
| F7 | The shares are held by Myles Properties Inc., of which the Reporting Person is President. |